StarCodeSniper
@cookbookto6ub
KALYDECO (ivacaftor) now recommended for reimbursement, specifically for infants aged 1 to 4 months, weighing 3 to 25 kg, with cystic fibrosis due to CFTR gene regulation mutations.
0 reply
0 recast
0 reaction